Globe Life Inc. (NYSE:GL – Get Free Report) CEO Frank Svoboda sold 10,000 shares of Globe Life stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at $9,004,053.60. The trade was a 15.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Globe Life Trading Up 1.0%
Shares of GL opened at $169.07 on Wednesday. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $170.11. The company has a 50-day moving average of $153.91 and a 200 day moving average of $145.06. The firm has a market capitalization of $13.13 billion, a price-to-earnings ratio of 11.69 and a beta of 0.49. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the business earned $3.07 EPS. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, research analysts expect that Globe Life Inc. will post 15.64 EPS for the current year.
Globe Life Announces Dividend
Analysts Set New Price Targets
GL has been the subject of several recent research reports. Evercore set a $157.00 price target on shares of Globe Life in a report on Wednesday, February 18th. Truist Financial boosted their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Morgan Stanley boosted their price target on shares of Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, May 21st. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Finally, Piper Sandler lifted their price objective on shares of Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Globe Life has an average rating of “Moderate Buy” and an average target price of $174.11.
Read Our Latest Stock Analysis on Globe Life
Institutional Trading of Globe Life
A number of hedge funds have recently added to or reduced their stakes in the company. Compound Planning Inc. boosted its holdings in Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after buying an additional 82 shares in the last quarter. Root Financial Partners LLC boosted its holdings in Globe Life by 23.3% during the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after buying an additional 83 shares in the last quarter. Transcend Capital Advisors LLC boosted its holdings in Globe Life by 3.9% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares in the last quarter. Natural Investments LLC boosted its holdings in Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after buying an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after buying an additional 87 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Further Reading
- Five stocks we like better than Globe Life
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
